An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor Immunity.
Yao Y, Wu M, Wang Y, Liao Z, Yang Y, Liu Y, Shi J, Wu W, Wei X, Xu J, Guo Y, Dong X, Che J, Wang J, Gu Z.
Yao Y, et al. Among authors: guo y.
Adv Mater. 2025 Jan;37(3):e2411454. doi: 10.1002/adma.202411454. Epub 2024 Nov 20.
Adv Mater. 2025.
PMID: 39568237